Why the study?
Does kaolin-activated whole blood thromboelastogram (TEG) provide additional benefit over traditional coagulation tests for monitoring the effect of dabigatran?
Does kaolin-activated whole blood thromboelastogram (TEG) provide additional benefit over traditional coagulation tests for monitoring the effect of dabigatran?
Kaolin-activated whole blood TEG does not add additional benefit to traditional coagulation tests when monitoring the effect of dabigatran.
Answers are grounded in this paper and cite their sources.
TEG correlation with coagulation tests in dabigatran patients is hypothesis-generating; larger perioperative studies needed before clinical use.
Dabigatran is a direct thrombin inhibitor, which is increasingly likely to be encountered in patients presenting for surgery. This study examines whether there is a consistent effect of dabigatran on the thromboelastogram (TEG) and whether this correlates with the effects of dabigatran on traditional coagulation parameters. Twenty patients taking dabigatran had blood sampled for kaolin-activated whole blood TEG analysis and routine coagulation testing. There was a statistically significant correlation between thrombin clotting time (TCT) and R-time (R=0.77, P=0.0001) and between activated partial thromboplastin time (APTT) and R-time (R=0.68, P=0.0013), but not between TCT and alpha-angle (R=-0.4232, P=0.071). Despite the moderate to high correlation between the TEG R-time and the TCT and APTT, there appeared to be no consistent effect of dabigatran on the TEG. These findings suggest that use of kaolin-activated whole blood TEG does not add additional benefit to traditional coagulation tests when monitoring the effect of dabigatran.
No takes yet. Share an insight, caveat, or question.
Aho et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: